Evidence map›Paper›PMID 38153724›Full record

ArticleJAMA otolaryngology-- head & neck surgery2024

National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.

Sarah C Nyirjesy, Hilary C McCrary, Songzhu Zhao, Ryan T Judd, Janice L Farlow, Nolan B Seim, Enver Ozer, Amit Agrawal, Matthew O Old, James W Rocco and 2 more

Open access · greenAbstract read
In one paragraph

Article in JAMA otolaryngology-- head & neck surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sarah C NyirjesyDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Hilary C McCraryDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Songzhu ZhaoDepartment of Biomedical Informatics and Center for Biostatistics, The Ohio State University College of Medicine, Columbus.
Ryan T JuddDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Janice L FarlowDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Nolan B SeimDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Enver OzerDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Amit AgrawalDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Matthew O OldDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
James W RoccoDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Stephen Y KangDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
Catherine T HaringDepartment of Otolaryngology-Head and Neck Surgery, The Ohio State University College of Medicine, Columbus.
The Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: As the incidence of oropharyngeal squamous cell carcinoma (OPSCC) continues to rise in the US, an increasing number of patients are being treated with transoral robotic surgery (TORS). Readmission following surgery can potentially delay initiation of adjuvant treatment and affect survival outcomes. Objective: To identify risk factors for 30-day postoperative readmission in patients undergoing TORS for OPSCC. Design, Setting, and Participants: This retrospective, population-based cohort study used data from the Nationwide Readmissions Database from 2010 to 2017. All patients undergoing TORS for OPSCC were identified using International Classification of Diseases codes and included. Exclusion criteria were age younger than 18 years or incomplete information regarding index admission or readmission. The analysis was performed from April to October 2023. Exposure: TORS for OPSCC. Main Outcomes and Measures: Univariate and multivariate analyses were performed to determine factors associated with 30-day readmission. Covariates included demographics and medical comorbidities, socioeconomic factors, hospital characteristics, and surgical details. Trends in readmission over time, reasons for readmission, and characteristics of the readmission were also examined. Results: A weighted total of 5544 patients (mean [SD] age, 60.7 [0.25] years; 4475 [80.7%] male) underwent TORS for OPSCC. The overall readmission rate was 17.5% (n = 971), and these rates decreased over the study period (50 of 211 patients [23.7%] in 2010 vs 58 of 633 patients [9.1%] in 2017). Risk factors associated with readmission included male sex (adjusted odds ratio [AOR], 1.54; 95% CI, 1.07-2.20) and a diagnosis of congestive heart failure (AOR, 2.42; 95% CI, 1.28-4.58). Factors associated with decreased rate of readmission included undergoing concurrent selective neck dissection (AOR, 0.30; 95% CI, 0.22-0.41). Among the 971 readmissions, the most common readmission diagnoses were bleeding (151 [15.6%]), electrolyte and digestive problems (44 [4.5%]), pneumonia (44 [4.5%]), and sepsis (26 [2.7%]). Conclusions and Relevance: In this cohort study, readmission rates following TORS for oropharynx cancer decreased over time; however, a subset of patients required readmission most commonly related to bleeding, infection, and electrolyte imbalance. Concurrent neck dissection may be protective against readmission. Elucidation of risk factors for readmission after TORS for OPSCC offers opportunities for evidence-based shared decision-making, quality improvement initiatives, and improved patient counseling.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal NeoplasmsRobotic Surgical ProceduresAdolescentCohort StudiesElectrolytesFemaleHumansMaleMiddle AgedPatient ReadmissionRetrospective StudiesSquamous Cell Carcinoma of Head and NeckElectrolytes

Identifiers

PMID38153724
PMCPMC10853828
OpenAlexW4390347616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.